Carel Van Der Merwe
Mediclinic International PLC
Dr. Carel Aron Van der Merwe has been appointed as Chief Executive Officer - Designate of the Company., effective August 1, 2018. He currently serves as Chief Clinical Officer of the Company. Dr Van der Merwe joined Mediclinic in 1999 and has been a member of the Group’s Executive Committee since 2008. He established the Clinical Information, Advanced Analytics, Health Information Management and Clinical Services functions at Mediclinic and has been Group Chief Clinical Officer since 2007. He was appointed as a director of Mediclinic International Limited in 2010 up to the combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited. He is also a member of the Board of Directors at Wits Donald Gordon Medical Centre (Pty) Ltd and is the Chairman of the Board of Trustees for the Remedi Medical Aid Scheme. Dr Van der Merwe obtained qualifications in Advanced Management (Harvard Business School, USA), a Fellowship in Anaesthesia (College of Anaesthesiologists, South Africa) where he was the recipient of the Jack Abelsohn Medal and a Bachelor of Medicine and Bachelor of Surgery (University of Stellenbosch, South Africa).
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology